l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Asparaginase‐associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2016
- Recent developments in l-asparaginase discovery and its potential as anticancer agentCritical Reviews in Oncology/Hematology, 2016
- Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine DepletionMolecular Cell, 2014
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemiaLeukemia, 2014
- The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical TrialBlood Cancer Journal, 2014
- Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?International Journal of Hematology, 2011
- Conservative treatment of L‐asparaginase‐associated lipid abnormalities in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2010
- Polygenic determinants of severe hypertriglyceridemiaHuman Molecular Genetics, 2008
- Asparaginase-Associated Lipid Abnormalities in Children With Acute Lymphoblastic LeukemiaBlood, 1997
- Toxic and antineoplastic effects of l-asparaginase: Study of mice with lymphoma and normal monkeys and report on a child with leukemiaCancer, 1966